SUPREME-HN: A Retrospective Biomarker Study Assessing the Prognostic Value of PD-L1 Expression in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

Journal of Translational Medicine - United Kingdom
doi 10.1186/s12967-019-02182-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Intratumor Heterogeneity of PD-L1 Expression in Head and Neck Squamous Cell Carcinoma

British Journal of Cancer
Cancer ResearchOncology
2019English

XPA–A Biomarker With Potential Prognostic Value in Patients With Oropharyngeal Head and Neck Squamous Cell Carcinoma

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

121 Prognostic Value of INPP5A Expression in Recurrent and Metastatic Cutaneous Squamous Cell Carcinoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

A Phase II Study of Temsirolimus and Erlotinib in Patients With Recurrent and/or Metastatic, Platinum-Refractory Head and Neck Squamous Cell Carcinoma

Oral Oncology
Cancer ResearchOral SurgeryOncology
2013English

Genetic Landscape of Metastatic and Recurrent Head and Neck Squamous Cell Carcinoma

Journal of Clinical Investigation
Medicine
2016English

Retrospective Investigation of the Prognostic Value of the Β1 Integrin Expression in Patients With Head and Neck Squamous Cell Carcinoma Receiving Primary Radio(chemo)therapy

PLoS ONE
Multidisciplinary
2018English

Pcn105 - Economic Burden of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Regulatory T Cells and Their Prognostic Value for Patients With Squamous Cell Carcinoma of the Head and Neck

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2009English

PD‑L1 Promotes Head and Neck Squamous Cell Carcinoma Cell Growth Through mTOR Signaling

Oncology Reports
MedicineCancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy